400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2025-12-18
癌症治疗药物研发商
医药研发/制造
化学&生物药
2025-07-14
阿尔茨海默病疗法研究商
医药研发/制造
化学&生物药
Schmidt;
Schmidt;
Industrial Bank of Korea;
Industrial Bank of Korea;
IMM Investment;
Hana Ventures;
S&S Investment;
Shinhan Capital;
TS Investment;
LB投资;
Dayli Partners;
Company K Partners;
Quad Asset Management;
Aju IB Investment;
Korea Development Bank;
Woori Venture Partners;
DSC Investment
2025-01-01
3D牙科医疗软件开发商
医疗信息化
2023-11-27
小分子药物研发商
医药研发/制造
化学&生物药
2022-05-25
RNA干扰(RNAi)技术疗法开发商
医药研发/制造
化学&生物药
Company K Partners;
Company K Partners;
Welcome AM;
Welcome AM;
IMM Investment;
Focus Asset Management;
Solidus Investment;
KB Investment;
Shinhan Capital
2022-03-16
溶瘤病毒免疫疗法研发商
医药研发/制造
化学&生物药
2021-09-23
基因疗法研发商
医药研发/制造
化学&生物药
Sequoia Capital;
Sequoia Capital;
Company K Partners;
Company K Partners;
DCVC Bio;
Timefolio Asset Management;
SK Holdings;
IMM Investment;
KTB Network;
KB Investment;
Bow Capital;
Dayli Partners;
Eli Lilly;
Korea Investment Partners
2021-09-23
基因疗法研发商
医药研发/制造
化学&生物药
Sequoia Capital;
Sequoia Capital;
Bow Capital;
Bow Capital;
SK Holdings;
DCVC Bio;
Timefolio Asset Management;
IMM Investment;
KB Investment;
Dayli Partners;
Korea Investment Partners;
Company K Partners;
KTB Network;
Eli Lilly
2020-01-06
数字治疗服务提供商
医疗器械
医疗器械软件
Company K Partners;
Company K Partners;
K2 Investment Partners;
K2 Investment Partners;
KTB Network
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10